Novartis treatment for vision loss meets goals in study
February 27, 2015 at 11:30 AM EST
ZURICH, Feb 27 (Reuters) - Swiss drugmaker Novartis said on Friday its treatment for a leading cause of age-related blindness had met its primary goals in a study and could potentially pave the way for less frequent dosing compared to a drug already on the market.
